TWC
KNSA icon

TD Waterhouse Canada’s Kiniksa Pharmaceuticals KNSA Stock Holding History

TD Waterhouse Canada’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
16,691
+724
+5% +$37.6K ﹤0.01% 696
2026
Q1 		$768K Buy
15,967
+4,520
+39% +$200K ﹤0.01% 750
2025
Q4 		$471K Buy
11,447
+9,407
+461% +$377K ﹤0.01% 708
2025
Q3 		$78.8K Buy
2,040
+1,925
+1,674% +$62.5K ﹤0.01% 1083
2025
Q2 		$3.13K Buy
115
+15
+15% +$382 ﹤0.01% 1680
2025
Q1 		$2.17K Buy
+100
New +$2.06K ﹤0.01% 1671

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

TD Waterhouse Canada's KNSA Position: Q2 2026 in Review

TD Waterhouse Canada increased its Kiniksa Pharmaceuticals (KNSA) stake by 4.5% in Q2 2026, buying an estimated $37.6K and bringing the position to 16,691 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #696.

TD Waterhouse Canada first reported a position in KNSA in Q1 2025 and has held it in 6 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • TD Waterhouse Canada held 16,691 shares of Kiniksa Pharmaceuticals worth $1.05M as of Q2 2026.
  • TD Waterhouse Canada bought 724 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $37.6K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #696 holding.
  • TD Waterhouse Canada first reported a position in Kiniksa Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.